467 related articles for article (PubMed ID: 34438122)
1. Novel cinnamic acid magnolol derivatives as potent α-glucosidase and α-amylase inhibitors: Synthesis, in vitro and in silico studies.
Hu CM; Wang WJ; Ye YN; Kang Y; Lin J; Wu PP; Li DL; Bai LP; Xu XT; Li BQ; Zhang K
Bioorg Chem; 2021 Nov; 116():105291. PubMed ID: 34438122
[TBL] [Abstract][Full Text] [Related]
2. Syntheses, in vitro α-amylase and α-glucosidase dual inhibitory activities of 4-amino-1,2,4-triazole derivatives their molecular docking and kinetic studies.
Yeye EO; Kanwal ; Mohammed Khan K; Chigurupati S; Wadood A; Ur Rehman A; Perveen S; Kannan Maharajan M; Shamim S; Hameed S; Aboaba SA; Taha M
Bioorg Med Chem; 2020 Jun; 28(11):115467. PubMed ID: 32327353
[TBL] [Abstract][Full Text] [Related]
3.
Zheng PF; Xiong Z; Liao CY; Zhang X; Feng M; Wu XZ; Lin J; Lei LS; Zhang YC; Wang SH; Xu XT
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1938-1951. PubMed ID: 34459690
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of azachalcones, their α-amylase, α-glucosidase inhibitory activities, kinetics, and molecular docking studies.
Saleem F; Kanwal ; Khan KM; Chigurupati S; Solangi M; Nemala AR; Mushtaq M; Ul-Haq Z; Taha M; Perveen S
Bioorg Chem; 2021 Jan; 106():104489. PubMed ID: 33272713
[TBL] [Abstract][Full Text] [Related]
5. A facile approach synthesis of benzoylaryl benzimidazole as potential α-amylase and α-glucosidase inhibitor with antioxidant activity.
Aroua LM; Almuhaylan HR; Alminderej FM; Messaoudi S; Chigurupati S; Al-Mahmoud S; Mohammed HA
Bioorg Chem; 2021 Sep; 114():105073. PubMed ID: 34153810
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and bioactivities evaluation of oleanolic acid oxime ester derivatives as
Deng XY; Ke JJ; Zheng YY; Li DL; Zhang K; Zheng X; Wu JY; Xiong Z; Wu PP; Xu XT
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):451-461. PubMed ID: 35012401
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro evaluation of chlorogenic acid amides as potential hypoglycemic agents and their synergistic effect with acarbose.
Cardullo N; Floresta G; Rescifina A; Muccilli V; Tringali C
Bioorg Chem; 2021 Dec; 117():105458. PubMed ID: 34736132
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of obovatol and related neolignan analogues as α-glucosidase and α-amylase inhibitors.
Sciacca C; Cardullo N; Pulvirenti L; Travagliante G; D'Urso A; D'Agata R; Peri E; Cancemi P; Cornu A; Deffieux D; Pouységu L; Quideau S; Muccilli V
Bioorg Chem; 2024 Jun; 147():107392. PubMed ID: 38723423
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Evaluation of a Series of Oleanolic Acid Saponins as α-Glucosidase and α-Amylase Inhibitors.
Guo T; Wu S; Guo S; Bai L; Liu Q; Bai N
Arch Pharm (Weinheim); 2015 Sep; 348(9):615-28. PubMed ID: 26207761
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of indole derivatives as diabetics II inhibitors and enzymatic kinetics study of α-glucosidase and α-amylase along with their in-silico study.
Taha M; Alrashedy AS; Almandil NB; Iqbal N; Anouar EH; Nawaz M; Uddin N; Chigurupati S; Wadood A; Rahim F; Das S; Venugopal V; Nawaz F; Khan KM
Int J Biol Macromol; 2021 Nov; 190():301-318. PubMed ID: 34481854
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional isoxazolidine derivatives as α-amylase and α-glucosidase inhibitors.
Ghabi A; Brahmi J; Alminderej F; Messaoudi S; Vidal S; Kadri A; Aouadi K
Bioorg Chem; 2020 May; 98():103713. PubMed ID: 32151966
[TBL] [Abstract][Full Text] [Related]
12. Isatin-hydrazide conjugates as potent α-amylase and α-glucosidase inhibitors: Synthesis, structure and invitro evaluations.
Abbasi I; Nadeem H; Saeed A; Kharl HAA; Tahir MN; Naseer MM
Bioorg Chem; 2021 Nov; 116():105385. PubMed ID: 34600331
[TBL] [Abstract][Full Text] [Related]
13. Multicomponent reaction for the synthesis of new 1,3,4-thiadiazole-thiazolidine-4-one molecular hybrids as promising antidiabetic agents through α-glucosidase and α-amylase inhibition.
Gummidi L; Kerru N; Ebenezer O; Awolade P; Sanni O; Islam MS; Singh P
Bioorg Chem; 2021 Oct; 115():105210. PubMed ID: 34332231
[TBL] [Abstract][Full Text] [Related]
14. Dihydropyridines as potential α-amylase and α-glucosidase inhibitors: Synthesis, in vitro and in silico studies.
Yousuf H; Shamim S; Khan KM; Chigurupati S; Kanwal ; Hameed S; Khan MN; Taha M; Arfeen M
Bioorg Chem; 2020 Mar; 96():103581. PubMed ID: 31978686
[TBL] [Abstract][Full Text] [Related]
15. Novel tetrahydrobenzo[b]thiophen-2-yl)urea derivatives as novel α-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti-hyperglycemic evaluation.
Xie HX; Zhang J; Li Y; Zhang JH; Liu SK; Zhang J; Zheng H; Hao GZ; Zhu KK; Jiang CS
Bioorg Chem; 2021 Oct; 115():105236. PubMed ID: 34411978
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in silico inhibition properties of fucoidan against α-amylase and α-D-glucosidase with relevance to type 2 diabetes mellitus.
S LS; Raghu C; H A A; P A
Carbohydr Polym; 2019 Apr; 209():350-355. PubMed ID: 30732817
[TBL] [Abstract][Full Text] [Related]
17. Exploring efficacy of indole-based dual inhibitors for α-glucosidase and α-amylase enzymes: In silico, biochemical and kinetic studies.
Kawde AN; Taha M; Alansari RS; Almandil NB; Anouar EH; Uddin N; Rahim F; Chigurupati S; Nawaz M; Hayat S; Ibrahim M; Elakurthy PK; Vijayan V; Morsy M; Ibrahim H; Baig N; Khan KM
Int J Biol Macromol; 2020 Jul; 154():217-232. PubMed ID: 32173438
[TBL] [Abstract][Full Text] [Related]
18. Novel C-2 Symmetric Molecules as α-Glucosidase and α-Amylase Inhibitors: Design, Synthesis, Kinetic Evaluation, Molecular Docking and Pharmacokinetics.
Shahzad D; Saeed A; Larik FA; Channar PA; Abbas Q; Alajmi MF; Arshad MI; Erben MF; Hassan M; Raza H; Seo SY; El-Seedi HR
Molecules; 2019 Apr; 24(8):. PubMed ID: 30999646
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and molecular docking studies of imines as α-glucosidase and α-amylase inhibitors.
Aispuro-Pérez A; López-Ávalos J; García-Páez F; Montes-Avila J; Picos-Corrales LA; Ochoa-Terán A; Bastidas P; Montaño S; Calderón-Zamora L; Osuna-Martínez U; Sarmiento-Sánchez JI
Bioorg Chem; 2020 Jan; 94():103491. PubMed ID: 31818480
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of α-glucosidase and α-amylase by herbal compounds for the treatment of type 2 diabetes: A validation of in silico reverse docking with in vitro enzyme assays.
Tolmie M; Bester MJ; Apostolides Z
J Diabetes; 2021 Oct; 13(10):779-791. PubMed ID: 33550683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
